Article metrics

Download PDFPDF

Extended report
Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation

 

Online download statistics by month:

Online download statistics by month: December 2017 to October 2022

AbstractFullPdf
Dec 201753854894
Jan 201811941241284
Feb 201832231290
Mar 2018753751188
Apr 2018580585161
May 201846447090
Jun 201848148696
Jul 201834734762
Aug 201843043063
Sep 201840240285
Oct 2018557557107
Nov 201850550689
Dec 201829229254
Jan 201938637396
Feb 2019371366133
Mar 2019540522130
Apr 201943542783
May 201943442199
Jun 2019438429127
Jul 201923722857
Aug 201916816558
Sep 201915814563
Oct 201920619072
Nov 2019157143105
Dec 201923422659
Jan 202016915776
Feb 202017516384
Mar 202018516962
Apr 202019517499
May 202017517074
Jun 202022921898
Jul 2020232216102
Aug 202015513775
Sep 2020185168121
Oct 2020242226107
Nov 2020181162113
Dec 202015814590
Jan 202122721577
Feb 202118517764
Mar 202122619984
Apr 202116114962
May 202119917688
Jun 202113511876
Jul 202113712680
Aug 202115814295
Sep 2021199182107
Oct 2021211192111
Nov 2021255240129
Dec 202116715980
Jan 202215514473
Feb 202217416884
Mar 202219819193
Apr 202220718858
May 202215514073
Jun 202220519760
Jul 202212111745
Aug 202216915654
Sep 202215214793
Oct 202217716164
Total16883163515396